A multi-centre retrospective study assessing efficacy and safety of lenalidomide therapy in patients with resistant or relapsed multiple myeloma and in patients with stable disease.
Latest Information Update: 31 May 2016
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 May 2016 New trial record